Status:
COMPLETED
Total Shoulder Arthroplasty Near-infrared Spectroscopy
Lead Sponsor:
Hospital for Special Surgery, New York
Conditions:
Cerebral Ischemia
Eligibility:
All Genders
18+ years
Brief Summary
The purpose of this study is to measure cerebral oxygenation and cardiac output of total shoulder replacement patients undergoing general anesthesia (GA) and positive-pressure ventilation (PPV). We h...
Eligibility Criteria
Inclusion
- Patients 18-99 undergoing total shoulder arthroplasty
- Planned general anesthesia + brachial plexus nerve block
- Planned arterial catheter
Exclusion
- Patients younger than 18 years older and older than 99
- Patients not intending to receive general anesthesia and peripheral nerve block
- Indication for endotracheal tube
- BMI ≥ 30
- Ejection Fraction (if known) \< 50%
- Known significant restrictive or obstructive pulmonary disease
- Patients with a history of transient ischemic attack (TIA) or stroke
- Patients with recent signs or symptoms of myocardial ischemia
- Current stress test positive for ischemia
- Intolerance to study medications
- pre-existing contraindication to regional anesthesia
- infection at block site
- pre-existing neurological injury to operative limb
- Non-English speaking patients
Key Trial Info
Start Date :
July 1 2014
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 1 2015
Estimated Enrollment :
34 Patients enrolled
Trial Details
Trial ID
NCT02198183
Start Date
July 1 2014
End Date
October 1 2015
Last Update
January 17 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital for Special Surgery
New York, New York, United States, 10021